Scientists on Monday hailed a breakthrough for severe asthma treatment as a study found that the condition can be controlled by a regular injection of an antibody, eliminating the need for an inhaler.
The SHAMAL study, led by academics at King’s College London, found that 92 per cent of patients who used benralizumab were able to safely reduce use of their inhaler. Six in ten patients were able to completely stop all use.
